Related Experiment Videos

Perioperative dexmedetomidine improves outcomes of cardiac surgery

Fuhai Ji1, Zhongmin Li, Hung Nguyen

  • 1Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

Circulation
|March 21, 2013
PubMed

Insights

Perioperative dexmedetomidine significantly reduced mortality and complications in cardiac surgery patients. This drug is associated with decreased 1-year mortality and fewer postoperative issues, including delirium.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Critical Care Medicine

Background:

  • Cardiac surgery carries a high risk of complications, mortality, and increased healthcare costs.
  • Identifying interventions to mitigate these risks is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the impact of perioperative dexmedetomidine on complications and mortality following cardiac surgery.
  • To determine if dexmedetomidine administration can improve patient safety and reduce adverse events.

Main Methods:

  • Retrospective study of 1134 patients undergoing coronary artery bypass surgery (with or without other procedures).
  • Comparison between patients receiving intravenous dexmedetomidine infusion and a control group.
  • Propensity score adjustment and multivariate logistic regression analysis were employed.

Main Results:

  • Dexmedetomidine use significantly decreased in-hospital, 30-day, and 1-year mortality rates.
  • The incidence of overall postoperative complications and delirium was notably reduced in the dexmedetomidine group.
  • Adjusted odds ratios indicated a protective effect of dexmedetomidine against mortality and delirium.

Conclusions:

  • Perioperative dexmedetomidine is associated with reduced postoperative mortality up to one year after cardiac surgery.
  • The use of dexmedetomidine can decrease the incidence of postoperative complications and delirium, enhancing patient recovery.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...